Urol. praxi, 2013; 14(4): 174-177

Alternatives of treatment in ejaculatio praecox

MUDr.Luděk Daneš, CSc., prof.PhDr.Petr Weiss, Ph.D.
Sexuologický ústav 1. LF UK a VFN, Praha

The premature or rapid ejaculation is a second most common sexual dysfunction. It creates difficulties for our patients as well as for their

partners. The treatment was not very successful until the recent time. With new psychofarmacological drugs, especially with new antidepressants,

are our possibilities much better. The authors provide an overview of the possible therapeutical approaches. The therapeut can

apply biological treatment or psychotherapy. The combination of both, with an accent on pharmacotherapy, may be the most successful.

Keywords: prevalence of ejaculatio praecox, etiology, biological therapy, psychotherapy, recent news in the treatment

Published: October 27, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Daneš L, Weiss P. Alternatives of treatment in ejaculatio praecox. Urol. praxi. 2013;14(4):174-177.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Basar MM, Erdal A, Ferhat M, et al. Terazosin in the treatment of premature ejaculation: a short term follow-up. Internat. Urol. and Nephrol., 2005; 37(4): 773-777. Go to original source... Go to PubMed...
    2. Daneš L. Předčasná ejakulace. 1. Vydání. Grada, 2011.
    3. Gallo L, Perdona S, Gallo A. The role of short frenulum and the effects of frenulectomy on premature ejaculation. J. Sex. Med., 2010; 7(3): 1269-1276. Go to original source... Go to PubMed...
    4. Giuliano F, Hellstrom WJG. The pharmacological treatment of premature ejaculation. BJU Internat., 2008; 102(6): 102-109. Go to original source... Go to PubMed...
    5. Hyun JS, Kam SCh, Kwan OY. Changes of cerebral current source by audiovisual erotic stimuli in premature ejaculations patients. J. Sex. Med., 2008; 5(6): 1474-14814. Go to original source... Go to PubMed...
    6. Kolomazník M. Léčba předčasné ejakulace intermitentně podávaným sertralinem. Psychiatrie 2004; 8(2): 100-103.
    7. Kratochvíl S. Psychoterapie sexuálních dysfunkcí. V: P. Weiss: Sexuologie. Grada, Praha, 2010.
    8. Masters WH, Johnson VE. Human sexual inadequacy. Little, Brown and Comp., Boston. 1970.
    9. McMahon ChG, Waldinger M, Rowland D, et al. Ejaculatory disorders. In: H. Parot, J. Buvat (eds): Standard practice in sexual medicine. Blackwell Publishing, Massachusetts, 2006.
    10. Modi NB, Dresser MJ, Simon M, et al. Single- and multiple-dose phamacokinetics of dapoxetine hydrochloride, a novel agent fot he treatment of premature ejaculation. J. Clin. Pharm., 2006; 46(3): 301-309. Go to original source... Go to PubMed...
    11. Sadeghi-Nejad H, Watson R. Premature Ejaculation: Current medical treatment and new directions (CME). J. Sex. Med., 2008; 5(5): 1037-1050. Go to original source... Go to PubMed...
    12. Shamloul R, Nashaar A. Chronic prostatitis in premature ejaculation: a cohort study in 153 men. J. Sex. Med., 2006; 3(1): 150-154. Go to original source... Go to PubMed...
    13. Waldinger MD. Male ejaculation and orgasmic disorders. In: R. Balon RT. Segraves (eds): Handbook of sexual dysfunction. Taylor and Francis, Boca Raton, Fl. 2005.
    14. Wang WF, Wang Y, Minhas S, et al. Can sildenafil treat primary premature ejaculation? A prospective clinical study. Internat. J. Urol., 2007; 14(4): 331-355. Go to original source... Go to PubMed...
    15. Weiss P, Zvěřina J. Sexuální chování obyvatelstva České republiky. 4. vydání. DEMA, Praha. 2009.
    16. Zvěřina J. Sexuologie nejen pro lékaře. CERM, Akademické nakladatelství, Brno. 2003.

    Return to the content


    Urology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.